Vivodyne

South San Francisco, United States

Founded 2021

About Vivodyne

Vivodyne develops AI and robotics-powered human tissue testing platform to replace animal testing in drug discovery. Automated robotic lab processes 100,000+ human tissue experiments per run. $40M Series A (May 2025) led by Khosla Ventures, with NVIDIA. New 23,000 sq ft robotic lab in South San Francisco.

Key Products & Services

Human Tissue Testing Platform

Founded
2021
Employees
50-100
Funding
$118M

Quick Links

Company Details

Country
United States
City
South San Francisco
State
California
Type
commercial